HC Wainwright Raises Earnings Estimates for Alpha Cognition

Key Points

• HC Wainwright has raised its earnings estimates for Alpha Cognition Inc. for Q3 2025, expecting a loss of ($0.39) per share, an improvement from the previous forecast of ($0.45).
• Alpha Cognition reported a quarterly loss of ($0.65) per share, missing analyst expectations, and recorded $1.66 million in revenue against a consensus estimate of $2.32 million.
• Despite a "Buy" rating from HC Wainwright and a target price of $18.00, Wall Street Zen downgraded Alpha Cognition from "hold" to "sell."

Alpha Cognition Inc. (NASDAQ:ACOG - Free Report) - Research analysts at HC Wainwright boosted their Q3 2025 earnings per share estimates for shares of Alpha Cognition in a report released on Monday, October 20th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of ($0.39) per share for the quarter, up from their previous forecast of ($0.45). HC Wainwright currently has a "Buy" rating and a $18.00 target price on the stock. HC Wainwright also issued estimates for Alpha Cognition's Q4 2025 earnings at ($0.23) EPS, FY2025 earnings at ($1.45) EPS, Q1 2026 earnings at ($0.31) EPS, Q2 2026 earnings at ($0.27) EPS, Q3 2026 earnings at ($0.22) EPS, Q4 2026 earnings at ($0.15) EPS and FY2026 earnings at ($0.94) EPS.

Alpha Cognition (NASDAQ:ACOG - Get Free Report) last issued its earnings results on Thursday, August 14th. The company reported ($0.65) earnings per share for the quarter, missing the consensus estimate of ($0.46) by ($0.19). The firm had revenue of $1.66 million during the quarter, compared to analyst estimates of $2.32 million.

Separately, Wall Street Zen cut Alpha Cognition from a "hold" rating to a "sell" rating in a report on Saturday. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $18.00.

Alpha Cognition Stock Performance

ACOG opened at $6.85 on Wednesday. Alpha Cognition has a one year low of $3.75 and a one year high of $11.54. The stock has a market capitalization of $143.17 million, a PE ratio of -4.28 and a beta of 2.63. The business's 50 day moving average price is $8.03 and its 200 day moving average price is $8.16.

Insider Buying and Selling

In related news, Director Phillip Joseph Mertz sold 27,778 shares of the company's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $9.00, for a total value of $250,002.00. Following the transaction, the director directly owned 22,462 shares in the company, valued at approximately $202,158. This represents a 55.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Robert James Wills purchased 15,000 shares of the firm's stock in a transaction on Monday, August 18th. The shares were purchased at an average price of $8.49 per share, for a total transaction of $127,350.00. Following the completion of the purchase, the director directly owned 15,000 shares of the company's stock, valued at $127,350. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 14.00% of the company's stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC acquired a new position in Alpha Cognition during the second quarter worth $112,000. Massar Capital Management LP acquired a new position in Alpha Cognition during the second quarter worth $116,000. Villere ST Denis J & Co. LLC lifted its stake in Alpha Cognition by 201.0% during the first quarter. Villere ST Denis J & Co. LLC now owns 71,778 shares of the company's stock worth $363,000 after purchasing an additional 47,928 shares in the last quarter. Marshall Wace LLP acquired a new position in Alpha Cognition during the second quarter worth $600,000. Finally, Manatuck Hill Partners LLC lifted its stake in Alpha Cognition by 74.6% during the second quarter. Manatuck Hill Partners LLC now owns 117,000 shares of the company's stock worth $1,092,000 after purchasing an additional 50,000 shares in the last quarter.

About Alpha Cognition

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.